A recent study by Willis et al. 13 has demonstrated the prognostic role of FGD3 expression in a large cohort of breast cancer patients, compared with other important genes associated with proliferation as MKI6714, PCNA15 and AURKA16, regardless of ER status and molecular subtype. The gene discussed is FGD3; the disease is breast carcinoma.